^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Prostate Cancer |
| Drug: | abiraterone acetate (CYP17A1 inhibitor) + Firmagon (degarelix) (GnRH antagonist) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Prostate cancer: PRINCIPLES OF ANDROGEN DEPRIVATION THERAPY...ADT for Regional (N1,M0) Disease…Options for ADT are: Degarelix plus abiraterone
